CDK7-IN-22

• Description :

  CDK7-IN-22 (compound 101) is an CDK7 inhibitor with antitumor activity. CDK7-IN-22 shows selectivity on CDK7[1].

• UNSPSC :

  12352005

• Target :

  CDK

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cdk7-in-22.html

• Solubility :

  10 mM in DMSO

• Smiles :

  FC(F)(C1=CN=C(N[C@H]2CCCNC2)N=C1C3=CNC4=CC(N5CCCC5)=CC=C34)F

• Molecular Formula :

  C22H25F3N6

• Molecular Weight :

  430.47

• References & Citations :

  [1]Gu Xiaohui, et al. 、. TW110134941A.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2173190-60-6]